PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A topical 4% Quassia amara gel was evaluated for efficacy and safety compared to ketoconazole and ciclopiroxolamine [PMID:23545914]
Evidence suggests polyphenols, including quassia extract, may be beneficial for reducing facial erythema and papules [PMID:28650692]
Bark extracts inhibited indomethacin/bethanechol-induced gastric ulcers and reduced injury from hypothermic restraint-stress in animal models [PMID:12230107]
Leaf extracts showed significant suppressive activity against Plasmodium berghei berghei in mice [PMID:10617067]; simalikalactone E inhibited Plasmodium falciparum in vitro and Plasmodium vinckei petteri in vivo [PMID:19667291]
Standardized methanol extract showed antidiabetic activity in nicotinamide-streptozotocin-induced diabetic rats [PMID:21480415]
Pregnancy & lactation
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 12230107 (2002) — Antiulcerogenic activity of four extracts obtained from the bark wood of Quassia amara L. (Simaroubaceae). · Biological & pharmaceutical bulletin
- 2.PMID: 15259916 (2003) — Antibacterial and antifungal activities of Quassia undulata and Quassia amara extracts in vitro. · African journal of medicine and medical sciences
- 3.PMID: 10617067 (1999) — In vivo antimalarial activities of Quassia amara and Quassia undulata plant extracts in mice. · Journal of ethnopharmacology
- 4.PMID: 33544994 (2021) — Hepatoprotective effects of Quassia amara stem bark against cadmium-induced toxicity in male Wistar rats. · Journal of basic and clinical physiology and pharmacology
- 5.PMID: 17157466 (2007)